Pancreatic Cancer Research

ResearcherUniversity of Southern CaliforniaNo recent work listed

Ming Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8270-2070; OpenAlex author ID A5100351339. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 2 papers

Papers 7

  1. Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut m… Co-author DOI 10.1186/s12885-023-11557-z↗
  2. Pancreatic Ductal Adenocarcinoma: The Characteristics of Contrast-Enhanced Ultrasound Are Correlated with the Hypoxic Microenvironment. First author DOI 10.3390/diagnostics13203270↗
  3. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling. Co-author DOI 10.1186/s13046-022-02261-0↗
  4. BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment. Co-author DOI 10.3389/fpubh.2022.900853↗
  5. CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression. Co-author DOI 10.18632/oncotarget.14194↗
  6. Experimental study on the therapeutic effect and underlining mechanisms of positron in pancreatic cancer cells. First author DOI 10.18632/oncotarget.18366↗
  7. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Last author DOI 10.2147/ott.s92758↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuiliang Yu · 2 shared papers, 2017–2022 · strength 0.24
  2. Lan Zhou · 2 shared papers, 2017–2022 · strength 0.24
  3. Wei Xin · 2 shared papers, 2017–2022 · strength 0.24
  4. Fang Nie · 1 shared paper, 2023 · strength 0.22
  5. Lan Wang · 1 shared paper, 2023 · strength 0.22
  6. Zemin Zhu · 1 shared paper, 2023 · strength 0.19
  7. Zhijian Zhao · 1 shared paper, 2023 · strength 0.19
  8. Caixi Tang · 1 shared paper, 2023 · strength 0.19
  9. Lei Wang · 1 shared paper, 2022 · strength 0.16
  10. Jian Shi · 1 shared paper, 2022 · strength 0.16
  11. Yaming Li · 1 shared paper, 2017 · strength 0.08
  12. Ying Wang · 1 shared paper, 2017 · strength 0.08
  13. Yiwei Wang · 1 shared paper, 2017 · strength 0.07
  14. Mark W. Jackson · 1 shared paper, 2017 · strength 0.07
  15. Yebin Lu · 1 shared paper, 2016 · strength 0.07
  16. Weijia Sun · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.